Showing results (31-40 of 48) with videos related to
Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
A neutralizing anti-fibroblast growth factor 8 monoclonal antibody shows potent antitumor activity against androgen-dependent mouse mammary tumors in vivoNaoki Shimada, Toshihiko Ishii, Teruyoshi Imada, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|December 14, 2022
Translational nanomedicine potentiates immunotherapy in sarcoma by normalizing the microenvironmentFotios Mpekris, Myrofora Panagi, Christina Michael, et al.Nucleosides, Nucleotides & Nucleic Acids|October 21, 2003
Oligonucleotide N3' --> P5' thio-phosphoramidate telomerase template antagonists as potential anticancer agentsSergei Gryaznov, Akira Asai, Yuko Oshima, et al.Therapeutic Advances in Medical Oncology|August 8, 2018
Preclinical and phase I clinical studies of KW-2450, a dual IGF-1R/IR tyrosine kinase inhibitor, in combination with lapatinib and letrozoleHiroshi Umehara, Yoshimi Maekawa, Fumito Koizumi, et al.Blood|November 26, 2008
A pharmacodynamic study of the FLT3 inhibitor KW-2449 yields insight into the basis for clinical responseKeith W Pratz, Jorge Cortes, Gail J Roboz, et al.Breast Cancer Research and Treatment|February 3, 2007
A novel steroidal selective steroid sulfatase inhibitor KW-2581 inhibits sulfated-estrogen dependent growth of breast cancer cells in vitro and in animal modelsHiroyuki Ishida, Taisuke Nakata, Masayo Suzuki, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2004
The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult T-Cell leukemia/lymphomaTakashi Ishida, Shinsuke Iida, Yoshiki Akatsuka, et al.Bioorganic & Medicinal Chemistry Letters|July 9, 2014
Synthetic studies on mitotic kinesin Eg5 inhibitors: synthesis and structure-activity relationships of novel 2,4,5-substituted-1,3,4-thiadiazoline derivativesJunichiro Yamamoto, Nobuyoshi Amishiro, Kazuhiko Kato, et al.Bioorganic & Medicinal Chemistry|November 28, 2006
Design and synthesis of piperidine farnesyltransferase inhibitors with reduced glucuronidation potentialRieko Tanaka, Almudena Rubio, Nancy K Harn, et al.ESMO Open|November 16, 2016
Phase II study of erlotinib plus tivantinib (ARQ 197) in patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer just after progression on EGFR-TKI, gefitinib or erlotinibKoichi Azuma, Tomonori Hirashima, Nobuyuki Yamamoto, et al.Pageof 5